Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Kiray A et al. | 2013 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 3 mT |
| Rajendra P et al. | 2012 | intact cell/cell culture, sheep primary lymphocytes | 50/60 Hz, magnetic field | 5–100 µT |
| Juszczak K et al. | 2012 | intact cell/cell culture, urothelial cells (primary culture from urinary bladders of female Wistar rats) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 45 mT |
| Kaszuba-Zwoinska J et al. | 2012 | intact cell/cell culture, Mono Mac 6 cells (human monocytes) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
| Basile A et al. | 2011 | intact cell/cell culture, human melanoma cell lines (M14 and A375), animal, mouse/BALB/c nu/nu mic with M14 xenografts, whole body | magnetic field, 50/60 Hz | 30 A/m |
| Kim J et al. | 2010 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and IMR90 (human lung fibroblasts) | magnetic field, 50/60 Hz | 3–6 mT |
| Sun W et al. | 2010 | intact cell/cell culture, isolated villi tissue | magnetic field, low frequency, 50/60 Hz | 0.2–0.4 mT |
| Garip AI et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Kaszuba-Zwoinska J et al. | 2010 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 45 mT |
| Akdag MZ et al. | 2010 | animal, rat/Sprague-Dawley, whole body | magnetic field, low frequency, 50/60 Hz | 100–500 µT |
| Kim YW et al. | 2009 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 14–200 µT |
| Markkanen A et al. | 2008 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 100–300 µT |
| Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
| Roushangar L et al. | 2007 | animal, rat/Wistar | magnetic field, 50/60 Hz | 3 mT |
| Kroupova J et al. | 2007 | intact cell/cell culture, A549 (human adenocarcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Palumbo R et al. | 2006 | intact cell/cell culture, Jurkat cells (T lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, power transmission line, co-exposure | 1 mT |
| Santini MT et al. | 2005 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1–5 mT |
| Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
| Oda T et al. | 2004 | intact cell/cell culture, rat cerebellar granule cells | magnetic field, low frequency, 50/60 Hz | 300 mT |
| Ding GR et al. | 2004 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 5 mT |
| Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
| Lee JS et al. | 2004 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 0.1–0.5 mT |
| Lai H et al. | 2004 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 10–500 µT |
| Lopucki M et al. | 2003 | isolated organ, human placentae (after delivery) | magnetic field, 50/60 Hz | 2 mT |
| Berg H | 2003 | intact cell/cell culture, human myeloid leukemia cell line (K-562) and human non-Hodgkin lymphoma cell line (U-937) | magnetic field, 50/60 Hz, co-exposure | 8–55 mT |
| Berg H et al. | 2003 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) and U937 cells (human leukemic monocyte cell line) and human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 10–35 mT |
| Pirozzoli MC et al. | 2003 | intact cell/cell culture, LAN-5 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 1 mT |
| Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
| Verheyen GR et al. | 2003 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 80–800 µT |
| Kumlin T et al. | 2002 | animal, mouse/BALB/CŒDBA/2, whole body | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Pang L et al. | 2002 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 4.4–13 mT |
| Tian F et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells (Ku80-proficient) und xrs5 cells (Ku80-defizient; radiation sensitive mutant isolated from CHO-K1 cells) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Robison JG et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), HL-60R (human acute myeloid leukaemia cells with retinoic acid receptor-alhpa gene mutation) and Raji cells (human Burkitt lymphoma cells) | magnetic field, 50/60 Hz | 150 µT |
| McNamee JP et al. | 2002 | animal, mouse/ICR, whole body | magnetic field, 50/60 Hz | 1 mT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Tofani S et al. | 2001 | intact cell/cell culture, WiDr (colon adenocarcinoma cells), MCF-7 (breast adenocarcinoma cells), MRC-5 (embryonal lung cells), animal, mouse/CD-1 nu-nu (nude), whole body | magnetic field, static magnetic field, low frequency, 50/60 Hz, DC | 300 µT–2.5 mT |
| Cecconi S et al. | 2000 | intact cell/cell culture, ovarian follicles from mice (Swiss CD1) | magnetic field, low frequency, signals/pulses, 50/60 Hz | 1.5 mT |
| Khadir R et al. | 1999 | intact cell/cell culture, neutrophils (from human venous blood) | magnetic field, 50/60 Hz, co-exposure | 0.1–44 mT |
| Watson JM et al. | 1998 | intact cell/cell culture, human endometrial stromal fibroblasts (primary cells and ESF-I (N5) cell line) and 12 endometrial, ovarian, and prostate cancer cell lines and immortazized human ovarian epithelial cells (OV-I) | magnetic field, 50/60 Hz, co-exposure | 200 µT |
| Ismael SJ et al. | 1998 | animal, mouse/Swiss, whole body | magnetic field, static magnetic field, 50/60 Hz, DC | 0.4–20 µT |
| Simko M et al. | 1998 | intact cell/cell culture, AFC cells (human amniotic fluid cell line) and SCL II cells (human squamous cell carcinoma cell line) | magnetic field, 50/60 Hz | 1 mT |
| Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
| Hisamitsu T et al. | 1997 | intact cell/cell culture, HL-60 and ML-1 cells (human acute myeloid leukaemia cell lines) and human peripheral blood lymphocytes and human peripheral blood polymorphonuclear cells | magnetic field, 50/60 Hz | 45 mT |
| Narita K et al. | 1997 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) und peripheral blood cells | magnetic field, static magnetic field, 50/60 Hz | 45–180 mT |
| Blumenthal NC et al. | 1997 | intact cell/cell culture, rat tendon fibroblasts and rat bone marrow osteoprogenitor cells (Sprague-Dawley rat) | magnetic field, static magnetic field, intermediate frequency, 50/60 Hz | 0.25–0.5 mT |
| Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
| Phillips JL | 1986 | intact cell/cell culture, human colon carcinoma cell line (Colo 205) | electric field, magnetic field, 50/60 Hz | 0.1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
